Increased frequency of interferon-gamma-producing peripheral blood CD4(+) T cells in chronic hepatitis C virus infection

Citation
Y. Kawakami et al., Increased frequency of interferon-gamma-producing peripheral blood CD4(+) T cells in chronic hepatitis C virus infection, AM J GASTRO, 95(1), 2000, pp. 227-232
Citations number
47
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN journal
00029270 → ACNP
Volume
95
Issue
1
Year of publication
2000
Pages
227 - 232
Database
ISI
SICI code
0002-9270(200001)95:1<227:IFOIPB>2.0.ZU;2-G
Abstract
OBJECTIVES: To determine the profile of cytokine secretion by CD4(+) T help er (Th) cells in chronic hepatitis C virus (HCV) infection, we used flow cy tometry to determine the percentage of interferon (IFN)-gamma and interleuk in (IL)-4 producing cells from CD4+ T lymphocytes in peripheral blood obtai ned from patients chronically infected with HCV. METHODS: Peripheral blood mononuclear cells isolated from 89 HCV infected s ubjects (22 asymptomatic carriers, 56 patients with chronic hepatitis, and II patients with liver cirrhosis) and 34 healthy controls were stained with surface CD4 and intracellular IFN-gamma and IL-4. Serum soluble IL-2 recep tor (sIL-2R) levels were analyzed by ELISA. RESULTS: The frequency of IFN-gamma producing CD4(+) cells in asymptomatic HCV carriers, patients with chronic hepatitis, and patients with liver cirr hosis were significantly higher than those of healthy controls (p < 0.01, r espectively). In contrast, the percentages of IL-4-producing CD4+ cells wer e very low, and there were no significant correlations with disease progres sion. A significant elevation in serum sIL-2R levels was found in chronic H CV infection compared to healthy controls, and serum sIL-2R levels signific antly correlated with the frequency of IFN-gamma-producing cells. CONCLUSIONS: In HCV infected subjects, both serum sIL-2R and IFN-gamma are increased in chronic HCV infection no matter the stage of disease, meaning they are no different in asymptomatic carriers, patients with chronic hepat itis, and patients with liver cirrhosis, and that Th1 cytokine or Th1 cells may participate in the pathogenesis of liver damage in chronic HCV infecti on. (Am J Gastroenterol 2000;95:227-232. (C) 2000 by Am. Cell. of Gastroent erology)